Cite
HARVARD Citation
Murray, J. et al. (n.d.). S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis. American journal of gastroenterology. pp. S651-S652. [Online].